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Infectious bursal disease virus (IBDV) is a birnavirus that causes immunosuppressive disease in
chickens. The emergence of very virulent IBDV (vvIBDV) has brought new challenges for this disease.
The molecular determinants for the high pathogenicity of vvIBDV are not fully understood. Previous
studies focused mostly on the VP2 protein on segment A, but recent evidence suggests that segment B
also plays an important role. Previously we identiﬁed eight amino acid changes in the VP1 protein of
vvIBDV. In this study, we investigated effect of amino acids substitutions in VP1 on viral replication and
pathogenicity. We identiﬁed a Valine to Isoleucine substitution at amino acid position 4 (V4I) of VP1
that attenuates viral pathogenicity and reduces viral replication in SPF chickens but increases viral
replication in CEF cells. This study conﬁrms that VP1 of segment B play an important role in viral
replication and pathogenicity of vvIBDV.
& 2013 Elsevier Inc. All rights reserved.Introduction
Infectious bursal disease (IBD)is a highly contagious disease in
chickens commonly known as Gumboro disease. IBD was ﬁrst
reported in 1957 and spread rapidly throughout the United States
over the next decade (Lasher and Davis, 1997; McFerran et al.,
1980). Two different serotypes of IBDV have been described. The
pathogenic serotype 1 can be subdivided into classical, antigenic
variant and very virulent isolates while serotype 2 isolates are
apathogenetic in chickens(McFerran et al., 1980). Importantly,
very virulent IBDV (vvIBDV) strains with enhanced virulence in
chickens emerged in the late 1980 s. Classical vaccines proved
ineffective at controlling vvIBDV (Brown et al., 1994; Chettle
et al., 1989), making research on the molecular determinants of
the high virulence of vvIBDV urgent.
IBDV belongs to Birnaviridae, having a double-stranded RNA
(dsRNA) genome divided over two segments. The larger segment
A contains two overlapping open reading frames (ORFs), encoding
the nonstructural protein VP5, and a polyprotein which gives rise
to pVP2, VP3 and VP4. Segment B contains one large ORF
encoding VP1, the RNA dependent RNA polymerase responsible
for the replication of the genome and synthesis of mRNAs (Panll rights reserved.et al., 2007; von Einem et al., 2004). VP1 can be divided into three
functional regions, namely the N-terminus (aa 1–167), the central
polymerase domain (aa 168–658), and the C-terminus (aa 659–
878) (Garriga et al., 2007; Pan et al., 2007). The N terminus
domain is responsible for protein priming; the central domain
contains all structural motifs of RNA dependent RNA polymerase;
the C-terminus may prevent back-primed RNA synthesis during
protein priming (Garriga et al., 2007; Pan et al., 2007).
Recent advances in generating IBDV mutants by reverse
genetics, has allowed for the identiﬁcation of speciﬁc amino acids
in VP2 that are involved in the virulence and cell tropism of IBDV
(Brandt et al., 2001; Mundt, 1999; van Loon et al., 2002). Several
recent reports have shown that VP1 on segment B may play a role
in viral pathogenesis and vvIBDV expansion (Boot et al., 2005;
Escaffre et al., 2013; Hon et al., 2006; Liu and Vakharia, 2004;
Nouen et al., 2012). However, the molecular determinants of VP1
that result in the high virulence of vvIBDV have not yet been
determined.
In a previous study, we sequenced and analyzed the full length
segment B of seven vvIBDV strains. After sequence alignment of
the VP1 protein, we found 4 V, 61I, 145 T, 287 A, 508 K, 511 S,
646 S, 687 P often appeared in vvIBDV while non-vvIBDV gen-
erally bear 4I, 61 V, 145 N, 287 T, 508 R, 511 R, 646 G, 687 S(Yu
et al., 2010). In this report, we address the question of whether
the eight cluster speciﬁc amino acids in VP1 of vvIBDV contribute
to viral replication and pathogenicity. The viral minigenome
F. Yu et al. / Virology 440 (2013) 204–209 205system is a simple and useful tool to characterize viral replication.
In the present study, we establish a segment B based minigenome
system for polymerase activity detection. We found that a single
V4I substitution can enhance polymerase activity in DF-1 cells.
Then, we generated IBDV V4I mutants using reverse genetics, and
found that V4I substitution in VP1 have effects on viral replication
and pathogenicity of vvIBDV in chickens.Fig. 2. Schematic of minigenome assay. The minigenome construct BLP was
composed of the ﬁreﬂy luciferase open reading frame ﬂanked by the 50 and 30
UTRs of segment B from vvIBDV HLJ0504. The cassette was cloned in an antisense
orientation between the hammerhead ribozyme (HamRz) and hepatitis delta
ribozyme (Hdv) and into eukarytic expression vector pCAGGS.
4000Results
Establishment of a IBDV polymerase activity assay
The VP1 protein of segment B can be divided into three
functional units, namely the N-terminal, the central polymerase
and the C-terminal domains. Very virulent strains of IBDV contain
three amino acid substitutions in the N-terminal domain of VP1;
four in the central polymerase domain and one in the C-terminal
domain (Yu et al., 2010). To investigate whether these eight
amino acids affect viral replication and pathogenicity, we intro-
duced clusters of amino acid substitutions in the three functional
domains of VP1 from vvIBDV strain HLJ0504. Three mutations
(V4I, I61V, and T145N) were introduced in the N-terminus, four
mutations (A287T, K508R, S511R, and S646G) were introduced
into the central domain and one mutation (P687S) was intro-
duced into the C-terminus (Fig. 1).
Since VP1 is an RNA-dependent RNA polymerase involved in
viral replication and transcription, we aimed to investigate
whether the eight amino acid substitutions found in non-virulent
IBDV had an effect on VP1 polymerase activity by developing
a minigenome system. A minigenome system has already been
described for segment A of IBDV (Ben Abdeljelil et al., 2008)
but not for segment B. We inserted the open reading frame of
a luciferase reporter gene ﬂanked by the 50 and 30 untranslated
regions of HLJ0504 segment B in an antisense orientation into an
eukaryotic expression plasmid pCAGGS (Fig. 2). The resultant
plasmid, named BLP, when expressed in the presence of viral
proteins from segments A and B, resulted in luciferase expression
with low background levels. Compared with the previous seg-
ment A derived minigenome system, of which the reporter gene
was inserted in the positive sense, we had a very low backgroundFig. 1. VP1 plasmids. Mutations were introduced into the three structural
domains of VP1 of vvIBDV strain HLJ0504. Black boxes indicate the N-terminal
domain, white boxes the central polymerase domain and the gray boxes the
C-terminal domain. For the N-terminal mutant, amino acids 4, 61 and 145 were
mutated (pCAGGS-HLJ-4/61/145); for central polymerase domain mutant, amino
acids 287, 508, 511 and 646 were mutated (pCAGGS-HLJ-287/508/511/646); for C
terminal domain mutant, amino acid 687 was mutated (pCAGGS-HLJ-687). The
three mutations found in the N-terminal domain were also introduced separately
(pCAGGS-HLJ-4, pCAGGS-HLJ-61, pCAGGS-HLJ-145).value due to the reporter gene was ﬂanked by antisense sequence
of viral 30UTR and 50UTR.Substitution of Val with Ile at amino acid position 4 enhance viral
polymerase activity
To investigate whether the change of the eight amino acids,
clustered in groups based on the functional domains of VP1, affects
viral polymerase activity in the segment B-derived minigenome
system, we expressed wild type or mutated VP1 along with BLP
and the proteins from segment A. As shown in Fig. 3, introducing
the amino acid substitutions at position 4, 61 and 145 in VP1
increased the polymerase activity 26-fold over wild-type VP1 in
DF-1 cells. Mutations in the central or C-terminal domain had no
signiﬁcant effect on polymerase activity. To further determine
which amino acid in the N-terminal domain was responsible for3000
1000
2000
0
R
el
at
iv
ev
ity
er
as
e 
ac
tiv
 p
ol
ym
e
pC
AG
GS
-H
LJ
-B
pC
AG
GS
-H
LJ
-68
7
pC
AG
GS
-H
LJ
-4
pC
AG
GS
-H
LJ
-61
pC
AG
GS
-H
LJ
-14
5
Co
ntr
ol
Pp
CA
GG
S-
HL
J-4
14
5/6
1/1
4
pC
AG
GS
-H
LJ
-28
7/5
08
/51
1/6
46
64
Fig. 3. RNA polymerase activity in DF-1 cells. DF-1 cells were co-transfected with
the BLP minigenome reporter segment, pCAGG-HLJ-A and either wild-type or
mutated segment B. The renilla luciferase expressing plasmid, pTK-RL, was
included as an internal transfection control. Thirty-six hours post transfection,
both ﬁreﬂy and renilla luciferase levels were measured, and renilla expression was
used to normalize the data across wells. The average of triplicate experiments are
shown with error bars that represent the standard deviation (þ/).
F. Yu et al. / Virology 440 (2013) 204–209206the increased polymerase activity we introduced each mutation
individually into VP1 (Fig. 1). Polymerase activity was increased
24-fold over wild-type by introducing isoleucine at position 4
(Fig. 3) while the other two mutations did not signiﬁcantly alter
viral polymerase activity. Taken together, the results indicate that a
V4I substitution in vvIBDV VP1 greatly enhances viral polymerase
activity in DF-1 cells.rvH-4B
rv4
8
6Substitution of Val with Ile at amino acid position 4 of VP1 enhance
viral replication in CEF cells
Since the V4I mutation greatly enhances viral polymerase
activity in DF-1 cells, we investigated whether this change
affected viral replication in cell culture. Since the segment A of
vvIBDV prevents growth in CEF cells, we generated reassortant
viruses utilizing segment A from a non-virulent IBDV strain Gt
and segment B with or without the V4I substitution (Table 1). CEF
cells were infected with either rH-4B which contain segment A
from a non-virulent IBDV strain Gt and segment B from vvIBDV
strain HLJ0504 or r4 which contain segment A from Gt and
segment B from HLJ0504 with V4I substitution. TCID50 titers were
measured at various times post infection. The r4 virus had
signiﬁcantly higher titers at 36, 48, 60 h post infection (Fig. 4)
indicating that the V4I substitution can enhance viral replication
in CEF cells.Table 1
Description of plasmids and viruses.
Plasmid used for transcription Rescued
virus
Main feature
pCAGGSmGtAHRT pCAGGS-
HLJ-B
rH-4B Segment A, non-vvIBDV Gt
Segment B, vvIBDV HLJ0504
pCAGGSmGtAHRT pCAGGS-
HLJ-4
r4 Segment A, non-vvIBDV Gt
Segment B, vvIBDV HLJ0504, and
4 mutated
pCAGGS-HLJ-A pCAGGS-
HLJ-B
rvH-4B Segment A, vvIBDV HLJ0504
Segment B, vvIBDV HLJ0504
pCAGGS-HLJ-A pCAGGS-
HLJ-4
rv4 Segment A, vvIBDV HLJ0504
Segment B, vvIBDV HLJ0504, and
4 mutated
rH-4B
r4
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Fig. 4. Growth curve of rH-4B in CEF cells. Conﬂuent monolayers of CEF cells were
inoculated with rH-4B or r4. Cell culture supernatants were harvested at 12, 24,
36, 48, 60, and 72 hpi. Viral titers were determined by TCID50 assay. Averages of
triplicate experiments are shown with error bars representing standard deviation
(þ/). Results were analyzed using student t-test.Substitution of Val with Ile at amino acid position 4 of VP1 reduces
viral replication and pathogenicity in SPF chickens
To determine if a V4I substitution in VP1 of vvIBDV alters viral
replication or virulence in SPF chickens, two groups of three-
week-old chickens were inoculated with 10 ELD50 of rvH-4B
which contain segment A and B of vvIBDV strain HLJ0504 and
rv4 which contain segment A and segment B with V4I substitu-
tion of vvIBDV HLJ0504 via ocular and intranasal routes (Table 1).
The whole genome sequencing of both viruses conﬁrmed there
are no unwanted or adapted mutations. To evaluate viral replica-
tion, real time RT-PCR was done to determine the viral genome
copy number of each sample, as done previously (Wang et al.,
2009). We found that rv4 had signiﬁcantly lower replication
abilities at 48, 72 and 96 h pi compared to rvH-4B (Fig. 5). Three
days post-infection, infected chickens began to die. Chickens
infected with rv4 had a signiﬁcantly lower mortality rate com-
pared to chickens infected with rvH-4B (Fig. 6). Additionally,
chickens infected with rv4 had a delayed death peak compared to
chickens infected with wild-type virus. These results indicate thatLo
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Fig. 5. Growth curve of rvH-4B in bursa of infected chickens. Groups of three-
week-old SPF chickens were inoculated with of either rvH-4B or rv4. At 24, 48, 72
and 96 hours post inoculation, three chickens were randomly selected and
euthanized from each group. The bursae of each chicken was removed and used
for quantiﬁcation of viral RNA loads using real time RT-PCR. Results were analyzed
using student t-test.
rv4
rvH-4B
ControlS
ur
vi
va
l r
at
ea
1 2 3 4 5 6 7
100
80
40
60
0
20
Days post infection
Fig. 6. Survival of SPF chickens infected with rvH-4B. Three-week-old SPF
chickens (n¼30/group) were inocualted via eye and nasal route with 10 ELD50
of rvH-4B, rv4 or PBS. Survival was assessed for up to 7 days.
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tion and viral pathogenicity in SPF chickens.Discussion
Outbreaks of vvIBDV pose a continual threat to the poultry
industry, and determining the molecular determinants of vvIBDV
virulence is an area of active research (Muller et al., 2003). In
previous studies, amino acids 253, 279 and 284 of VP2 were found
to be involved in the virulence, cell tropism and pathogenicity of
vvIBDV (Mundt, 1999). However, the role that VP1 of segment B
plays in viral pathogenesis and replication remains controversial.
Le Nouen et al., (2006) found that a naturally reassortant strain of
IBDV, with segment A from vvIBDV and segment B from a non-
virulent strain, had signiﬁcantly reduced pathogenicity compared
with full vvIBDV (Le Nouen et al., 2006). However, Boot et al.
generated a reassortant virus containing segment B of vvIBDV and
segment A from an attenuated strain, and reported that it did not
induce morbidity nor mortality (Boot et al., 2005).
When Liu et al. generated a recombinant virus with segment A
from a tissue culture-adapted strain and segment B from a bursal-
derived variant virus strain it demonstrated delayed replication
kinetics in cell culture. In chicken experiments showed that
bursal-derived variant virus replicate more efﬁciently and cause
severe bursa lesions while tissue culture-adapted strains replicate
less efﬁciently and cause milder bursa lesions. This result indi-
cates that VP1 may modulate viral replication and pathogenicity
in vivo (Liu and Vakharia, 2004). Nouen found that segment B
might inﬂuence viral virulence even when it does not affect viral
replication in chickens (Nouen et al., 2012).
In our study, we found that a single substitution at amino acid
position 4 of VP1 was sufﬁcient to elevate vvIBDV polymerase
activity in DF-1 cells. Position 4 is found in the N-terminal domain
of VP1, which is responsible for the protein priming activity of
IBDV (Pan et al., 2007). So the increase in polymerase activity may
due to a change in the efﬁciency of protein priming. However,
determining the mechanism of how the V4I substitution leads to
increased polymerase activity in cell culture will require further
investigation.
Changes in polymerase activity are commonly associated with
changes in replication and pathogenicity in other viruses (Gabriel
et al., 2005; Murayama et al., 2010). To evaluate the effect of the
V4I mutation on replication in CEF cells we used reverse genetics
to generate reassortant viruses containing segment A from a non-
virulent strain of IBDV and segment B from vvIBDV with or
without the V4I substitution. We found that an isoleucine at
position 4 is sufﬁcient to increase replication of reassortant IBDV
in CEF cells, which is consistent with the increase in polymerase
activity observed in DF-1 cells.
Reports indicate that VP1 is involved in viral replication
in vitro and in vivo. Liu and Vakharia, (2004) found that bursal-
derived VP1 had a negative effect on viral replication in vero and
CEF cells and a positive effect on replication in SPF chickens. In
our study, we found that V4I mutation on VP1 had a positive
effect on viral replication in CEF cells and a negative effect on viral
replication in SPF chickens compared with the wild type bursal
derived VP1 of vvIBDV strain HLJ0504. The single amino acid V4I
substitution changed the viral replication characteristics from a
bursal derived strain to a tissue culture derived strain. The
mechanism why the single mutation had the different effects
in vitro and in vivo still needs further investigation.
Usually, during the process of the pathogenic bursal derived
ﬁeld strains adapted to cell culture, the virulence will be atte-
nuated at the same time(Yamaguchi et al., 1996). By sequence
analysis, several aa changes occurred in both segments duringthis process, and V4I substitution in VP1 protein also occurs
during this process. To study the effect of the substitution in vivo,
we introduced the V4I substitution into segment B of vvIBDV
strain HLJ0504 and injected SPF chickens. We observed signiﬁ-
cantly reduced viral virulence in vivo compared to wild-type
vvIBDV. This might due to the reduced replication ability in
bursae by V4I substitution.
Liu and Vakharia (2004) also found that bursal-derived VP1
cause more severe bursa lesions than tissue culture strains.
However, the viruses Liu used are not vvIBDV strains and do
not cause mortality in chickens, so histopathological examination
was used to evaluate differences in virulence caused by VP1 (Liu
and Vakharia, 2004). In our study, to evaluate virulence, we
generated two vvIBDV mutants using the method we described
previously (Yu et al., 2012). We found that amino acid V4I
substitution inﬂuenced viral pathogenicity, decreasing mortality
rates compared to wild-type vvIBDV. Our results further strength-
ened that VP1 modulate viral replication and virulence, and
pinpoint the single V4I substitution in VP1 as a determinant of
viral replication and virulence. Nouen et al., (2012) also conﬁrmed
that segment B played a role in viral pathogenicity. They found
that exchange of different regions of segment B of an attenuated
strain CU1 with their counterpart B88 can not restore the whole
pathogenicity equivalent to the original virus. They claimed that
different regions of RdRp are essential for viral pathogenicity even
when it does not affect viral replication. But in our study, we
pinpointed a single amino acid V4I substitution has signiﬁcant
effect on viral pathogenesis and involved in viral replication
ability in CEF cells and in SPF chickens. The difference might
due to the different background of segment B we used in the
experiments. In our study, we used a segment B originated from a
vvIBDV strain, and we found the key determinant in segment B
for virulence attenuation. And in Nouen’s study, they used a
segment B from an attenuated IBDV strain, and tried to ﬁnd the
determinants for virulence enhancement (To restore the patho-
genicity of the original one mc88180). The mechanisms involved
in viral virulence enhancement and attenuation might be differ-
ent. And the different characteristics of the two virus strains may
also lead to this difference.
In summary, we conﬁrmed an important role for VP1 in the
viral replication and pathogenesis of vvIBDV. Further, we identi-
ﬁed position 4 of VP1 as an important determinant of viral
replication and pathogenicity. Replacing valine at this position
with isoleucine enhanced viral replication in CEF cells, but
reduced viral replication and attenuated viral pathogenicity in
SPF chickens. Since the characteristics of V4I mutation in VP1
protein enhanced the replication ability in CEF cells, and at the
same time reduced virulence in SPF chickens, this substitution
may be useful for live attenuated vaccine development.Materials and methods
Cells and viruses
DF-1 cells were maintained in Dulbecco’s modiﬁed Eagle’s
medium (DMEM) supplemented with 10% fetal bovine serum at
37 1C in a humidiﬁed incubator at 5% CO2. Primary chicken
embryo ﬁbroblast (CEF) cells were prepared from 10-day-old
embryonated eggs. CEF cells were maintained in DMEM supple-
mented with 2% fetal bovine serum, and used for propagation of
the virus, virus titration, and replication kinetics. vvIBDV strain
HLJ0504 was isolated from the ﬁeld and preserved in our lab (Yu
et al., 2012), and the attenuated Gt strain of IBDV was from the
vvIBDV Gx strain through continuous passage in speciﬁc-
F. Yu et al. / Virology 440 (2013) 204–209208pathogen-free chicken embryos for 5 generations and in chicken
embryo ﬁbroblasts for 20 generations (Wang et al., 2004).Construction of plasmids(i)Tabl
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primSegment B minigenome plasmids All the primers used are
listed in Table 2. The minigenome construct BLP was con-
structed as follows: The sequence coding for luciferase was
ampliﬁed from vector pGL-3 (Promega) with primers B-L-5U-
up and B-3U-L-low. The 50 and 30 UTR sequences of HLJ0504
were ampliﬁed from pCAGGS-HLJ0504B using primers BU1
and B-5U-L-low (50 UTR) and B-L-3U-up and BL1 (30 UTR).
Overlap extension PCR using primers B-L-5U-up, B-L-3U-up
and B-3U L-low was done to ﬂank the luciferase ORF with the
50 and 30 UTR sequences. The resulting fragment was PCR
ampliﬁed and fused in an antisense orientation with hammer-
head ribozyme (HamRz) and hepatitis delta ribozyme (Hdv)
using primers P7, P8 and P9, and then cloned into the pCAGGS
vector through Sac I and Kpn I. The resulting construct, named
BLP, consisted of the following elements, in order, as shown in
Fig. 2: CMV promoter- HamRz-50UTR, luciferase ORF, 30UTR all
in antisense orientation)-HDV-ribozyme (Fig. 2).(ii) Plasmids used for virus rescue. pCAGGS-HLJ-A and pCAGGS-HLJ-
B, containing the full length genome of segment A and B of
HLJ0504 downstream of CMV enhancer and beta chicken actin
promoter, were constructed previously(Yu et al., 2012).
pCAGGSmGtAHRT, which contains the full length genome of
segment A of non-vvIBDV strain Gt downstream of CMV enhan-
cer and beta chicken actin promoter was also constructed
previously(Qi et al., 2007). A series of mutations were introduced
into pCAGGS-HLJ-B by site directed mutagenesis. As shown in
Fig. 1, three plasmids were generated. The ﬁrst had three
mutations (V4I, I61V, and T145N) in the N-terminal domain of
VP1, the second has four mutations (A287T, K508R, S511R, and
S646G) in the central polymerase domain and the third has a
single mutation (P687S) in the C-terminus of the protein. As we
found that N terminal had effect on viral polymerase activity, we
generated three plasmids that had single mutations of V4I, I61V
and T145N in the N terminus of the VP1 protein (Fig. 1).e 2
ers used for generation of segment B derived minigenome.
me Nucleotide sequence
1 50–GGATACGATGGGTCTGACCCT-30
5U-L-low 50–TATGTTTTTGGCGTCTTCCATGGTGGCAGAATCATCAAGAAG-30
L-5U-up 50–CTTCTTGATGATTCTGCCACCATGGAAGACGCCAAAAACATA-30
3U-L-low 5’–CTTGAGTGGTTCCCATCATGGTTACACGGCGATCTTTCCGCC-30
L-3U-up 50–GGCGGAAAGATCGCCGTGTAACCATGATGGGAACCACTCAAG-30
1 50–GGGGGCCCCCGCAGGCGAAG-30
-up 50–TGAGGACGAAACTATAGGAAAGGAATTCCTATAGTC
GGGGGCCCCCGCAGGCGAAGG-30
-Low 50–CGGACCGCGAGGAGGTGGAGATGCCATGCCGACCCGGATACG
ATGGGTCTGACCCT-30
50–ATTAGAGCTCTGTTAAGCGTCTGATGAGTCCGTGAGGACGAAA
CTATAGGAAAG-30
50–GAGTGGACGTGCGTCCTCCTTCGGATGCCCAGGTCGGACCGC
GAGGAGGTGGAG-30
50–ATTAGGTACCCGCCCTCCCTTAGCCATCCGAGTGGACGTGCGT
CCTCCTTC-30
The luciferase reporter gene sequences are underlined, the ribozyme
ence are bold and Italic, the introduced restriction sites are highlighted by
s, The nucleotides without any symbols are viral gene sequences. ATTA in
ers P7 and P9 are protective bases.Luciferase-based polymerase activity assay
The reporter gene was ﬂanked by virus cis-acting replication
element which can be only recognized by viral polymerase
together with the replication involving proteins. The expression
level of the reporter gene reﬂects the activity of the polymerase.
DF-1 cells were transfected with BLP together with pTK-RL
(Promega), pCAGGS-HLJ-A, and wild-type or mutated pCAGGS-
HLJ-B. pTK-RL is an internal control plasmid encoding Renilla
luciferase and is used to normalize cell viability and transfection
efﬁciencies between wells. Transfection mixtures using the empty
vector pCAGGS were used as a negative control. After six hours,
the medium was replaced by DMEM with 10% FBS. Cell extracts
were harvested 36 h post transfection and luciferase activity was
assayed by using the Dual Luciferase assay kit (Promega). All
experiments were performed in triplicate. Table 3 summarizes
the plasmids used in this assay.
Generation of viruses via reverse genetics
Plasmids used to generate each virus are listed in Table 1. DF-1
cells were transfected with 1.5 mg of each plasmid mixed with
10 ml of Lipofectamine 2000 (Invitrogen) according to the manu-
facturer’s instructions. After 48 h, the cells were frozen and
thawed three times. For viruses of rH-4B and r4 which can grow
on CEF cells, the supernatant was added to CEF cells with 2% FBS-
supplemented medium. The monolayer was examined daily for
cytopathic effect. The full-length genomes of the rescued viruses
were ampliﬁed and sequenced as described. For viruses of rvH-4B
and rv4 which cannot grow on CEF cells, the supernatant was
injected into three-week-old SPF chickens. Chickens were exam-
ined daily, death being a sign of vvIBDV infection (Yu et al.,
2012).The full-length genomes of the rescued viruses were
ampliﬁed and sequenced as described(Qi et al., 2007).
Viral replication in CEFs
Conﬂuent CEF cells were infected with virus at a multiplicity of
infection of 0.01. Cell supernatants were collected at 12, 24, 36,
48, 60, and 72 h post infection. The experiments were repeated
three times. The average titers were calculated from three
independent experiments by the method of Reed-Muench.
Results were analyzed using student t-test. Differences were
considered signiﬁcant at po0.05.
Chicken experiments
Three-week-old SPF chickens were housed in isolators. Prior to
inoculation, chickens were conﬁrmed to be IBDV negative. To
examine mortality, three groups of chickens were inoculated via
the ocular route with 10 ELD50 of either rvH-4B or rv4. PBS wasTable 3
Description of plasmids for transfection.
Groups Plasmids for transfection
pCAGGS-HLJ-B pCAGGS-HLJ-A, pTK-RL, BLP, pCAGGS-HLJ-B
pCAGGS-HLJ-4/61/145 pCAGGS-HLJ-A, pTK-RL, BLP, pCAGGS-HLJ-4/61/
145
pCAGGS-HLJ-287/508/
511/646
pCAGGS-HLJ-A, pTK-RL, BLP, pCAGGS-HLJ-287/
508/511/646
pCAGGS-HLJ-687 pCAGGS-HLJ-A, pTK-RL, BLP, pCAGGS-HLJ-687
pCAGGS-HLJ-4 pCAGGS-HLJ-A, pTK-RL, BLP, pCAGGS-HLJ-4
pCAGGS-HLJ-61 pCAGGS-HLJ-A, pTK-RL, BLP, pCAGGS-HLJ-61
pCAGGS-HLJ-145 pCAGGS-HLJ-A, pTK-RL, BLP, pCAGGS-HLJ-145
control pCAGGS-HLJ-A, pTK-RL, BLP,pCAGGS
F. Yu et al. / Virology 440 (2013) 204–209 209used as a negative control. Chickens were monitored for clinical
symptoms daily. Signs of disease or death were monitored for a
period of 7 days. After 7 days, the bursae of three randomly
selected chickens from each group were removed. The viral RNA
was extracted using PureLink
TM
Viral RNA/DNA kit (Invitrogen)
according to the manufacturer’s instructions. RT-PCR was per-
formed to amplify and sequence the whole genome of segment A
and B to conﬁrm infection with the intended virus as described
previously (Qi et al., 2007).
To examine replication efﬁciency, three groups of chickens
were inoculated via the ocular route with 10 ELD50 of rvH-4B or
rv4. PBS was used as a negative control. At 1, 2, 3, and 4 days post
inoculation, three chickens from each group were randomly
selected and euthanized. The bursae of each chicken was removed
and used for quantiﬁcation of viral RNA loads using real time RT-
PCR. Bursae tissue was homogenized in chilled sterile phosphate-
buffered saline. The viral RNA was extracted using PureLink
TM
Viral RNA/DNA kit (Invitrogen) according to the manufacturer’s
instructions, and real-time RT-PCR was performed as described
previously(Wang et al., 2009). At the same time, RT-PCR was
performed to amplify and sequence the whole genome of seg-
ment A and B to conﬁrm infection with the intended virus as
described previously (Qi et al., 2007).Acknowledgment
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